Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT03157648
Other study ID # 581/2557
Secondary ID
Status Recruiting
Phase N/A
First received July 6, 2015
Last updated May 16, 2017
Start date January 2015
Est. completion date April 2018

Study information

Verified date May 2017
Source Mahidol University
Contact Pairin Simcharoen, MD.
Phone 0875427917
Email pairin072@gmail.com
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

Shivering is a physiologic response to early hypothermia in mammals. The definition of shivering is an involuntary, oscillatory muscular activity that augments metabolic heat production.

Routinely in post anesthetic care unit (PACU), the core temperature via tympanic membrane is always measured in all patients. Sometimes patients who have low temperature have no shivering symptom in other hand patients who have normal temperature have shivering symptom. This indicates that, only core temperature is not enough for predicting or detecting patients who will have shivering symptom in PACU.

In this study, investigators hypothesise that the core-peripheral temperature difference in postoperative period indicates patients who will have shivering symptom.

Thus, the aims of this study are to evaluate the relationship between core-peripheral temperature difference and shivering symptom in patients in PACU.


Description:

Humans are warm-blooded animal or homeotherms. They are able to regulate their body temperature which in physiologic range themselves. The body temperature is controlled by balancing heat production and heat loss. The normal body temperature refers to either core temperature (eg. tympanic membrane, esophagus, and intra-urinary bladder) or peripheral temperature (eg. skin, forehead, and axillar). Core temperature is the temperature of the deep tissues of the body. The normal range of core temperature is between 36.5-37.5 degree celsius. The peripheral temperature, in contrast to the core temperature, can be changed by many factors such as the temperature of the surroundings environment.

The term of hypothermia is the core temperature less than or equal to 36.4 degree celsius. When the body exposes to cold temperature, heat loss is decreased and heat production is increased as defense mechanism for keeping balance in several means: stop sweating, piloerection, cutaneous arterioles constriction, shivering, which increases heat production in skeletal muscles, conversion from fat to energy by mitochondria.Hypothermia is one of factors, which relates to postoperative complications.

Shivering is an oscillatory muscular activity that augments metabolic heat production. Vigorous shivering increases metabolic heat production up to 600% above basal level. Shivering is a common postoperative period complication. The pathophysiology of postoperative shivering remains unclear otherwise various mechanisms have been proposed. Shivering may happen as a thermoregulatory response to hypothermia or muscle hyperactivity with clonic or tonic patterns. Although cold-induced shivering is an obvious source of postanesthetic tremor. Some of the patients who suffer from shivering are believed to be nonthermoregulatory because their core temperatures remain normal. The incidence of postoperative shivering is 65% of patients after general anesthesia and 33% of patients after regional anesthesia.

This is the prospective observation clinical study. Investigators will observe shivering symptom and measure the patients' temperature at tympanic membrane, forehead, and dorsal of hand at many time points.


Recruitment information / eligibility

Status Recruiting
Enrollment 200
Est. completion date April 2018
Est. primary completion date April 2018
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion criteria

- Postoperative patient at PACU (Post Anesthesia Care Unit)

- Duration of operation from 1 to 4 hours

- The patients American Society of Anesthesiologist classification from I to III

- The patients' age from 18 years old

Exclusion criteria:

- The patients who reject or unwilling to participate

- The patient who was induced hypothermia in intra-operative period

- The patient who still has neuromuscular blocking agent drugs effect in PACU

- The patient with shock or receiving continuous vasopressor drugs

Withdrawal or termination criteria:

- The patient who has intra-operative or immediate post-operative cardiac arrest and/or death

Study Design


Related Conditions & MeSH terms


Intervention

Other:
observing for shivering symptom
In the PACU investigators measure body temperature of all patients at tympanic membrane, forehead, and dorsal of hand. Investigators calculate the difference between body temperature measure at tympanic membrane and forehead/dorsal of hand. Investigators observe the shivering symptom and grading for severity.

Locations

Country Name City State
Thailand Faculty of Medicine Siriraj Hospital, Mahidol University Bangkok Bangkoknoi

Sponsors (1)

Lead Sponsor Collaborator
Mahidol University

Country where clinical trial is conducted

Thailand, 

Outcome

Type Measure Description Time frame Safety issue
Primary Difference in temperature Difference in temperature measured at tympanic membrane and forehead immediate after arriving in PACU
Secondary Change in temperature Difference in temperature measured at tympanic membrane and dorsal hand immediate after arriving in PACU
Secondary Shivering symptom Severity of shivering symptom from 0 to 4 grade (0 = No shivering, 1 = No visible muscle activity, but one or more of piloerection, peripheral vasoconstriction or peripheral cyanosis, 2 = Muscular activity in only one muscle group, 3 = Moderate muscular activity in more than one muscle group, but not generalized shaking, 4 = Violent muscular activity that involves the entire body). immediate after arriving in PACU
See also
  Status Clinical Trial Phase
Recruiting NCT04730609 - Dexmedetomidine for Intraoperative Shivering in Scheduled Elective Cesarean Delivery Phase 4
Completed NCT02141412 - Intravenous Dexmedetomidine For The Quaity Of Emergence From General Anesthesia Phase 4
Not yet recruiting NCT06283771 - The Effect of Heated Socks Developed With Wearable Technology on Hypothermia, Thermal Comfort Perception and Shivering N/A
Completed NCT02436174 - Assessment Of Shivering With iSeismograph N/A
Completed NCT03302351 - Dexmedetomidine, Ketamine and Dexmetedomidine-Ketamine Combination for Control of Shivering During Regional Anaethesia Phase 4
Completed NCT03721432 - The Effect of Oral Pregabalin on Epidural-induced Shivering and Epidural Characteristics N/A
Not yet recruiting NCT03530007 - Anti-shivering Effect of Ondansetron Phase 2/Phase 3
Completed NCT03679065 - Prophylactic Paracetamol or Dexamethasone for Post-spinal Anesthesia Shivering Phase 4
Completed NCT03675555 - Prophylactic Mirtazapine or Dexamethasone for Post-spinal Anesthesia Shivering Phase 4
Completed NCT03679052 - Prophylactic Mirtazapine or Clonidine for Post-spinal Anesthesia Shivering Phase 4
Recruiting NCT04938219 - Shivering_Basel_Baden N/A
Active, not recruiting NCT05284409 - Comparative Study Between the Prophylactic Intravenous Administrations of Acetaminophen vs Dexamethasone vs Pethidine Regarding the Incidence of Shivering Induced by Single Shot Spinal Anesthesia in the Orthopedic Surgeries of the Lower Limbs Phase 4
Terminated NCT03497507 - Investigating the Effect of Acupressure on Shivering During a Cesarean Delivery in Women Who Were Previously Laboring With an Epidural N/A
Completed NCT03370562 - Dexmedetomidine After Cesarean for the Treatment of Nausea and Shivering N/A
Completed NCT05110469 - Comparison of MgSO4 Versus Meperidine for Prevention of Shivering During Spinal Anesthesia Phase 4
Not yet recruiting NCT03566628 - Post-anaesthetic Shivering Amongst Patients Undergoing Cerebral Angiography N/A
Completed NCT02967601 - Influence of Preoperative Anxiety on Shivering During Elective Caesarean Section Under Spinal Anaesthesia N/A
Recruiting NCT05765162 - Safe Brain Initiative, Operationalizing Precision Anaesthesia
Recruiting NCT04870541 - Nefopam Versus Ondansteron for Prevention of Post Spinal Shivering. Phase 4
Active, not recruiting NCT01669213 - Effects of Different Kinds, Different Doses of 5-HT3 Receptor Antagonists on Prevention of Hypotension N/A